Karyopharm Therapeutics | KPTI - Stock


Karyopharm Therapeutics reported $4.04M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
AbbVie USD 5.13B 78M Jun/2026
Abbott USD 6.99B 501M Mar/2026
Amgen USD 6.22B 34M Jun/2026
AstraZeneca USD 6.93B 362M Jun/2026
BioCryst Pharmaceuticals USD 6.06M 71K Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Incyte USD 112.54M 3.08M Jun/2026
J&J USD 15.14B 561M Jun/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
MacroGenics USD 9.5M 1.59M Mar/2026
Merck USD 6.21B 272M Jun/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.22B 66M Jun/2026
Novartis USD 6.29B 135M Mar/2026
Pfizer USD 9.94B 722M Jun/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Takeda JPY 1.45T 50.64B Jun/2026
TG Therapeutics USD 147.97M 18.94M Jun/2026
Ultragenyx Pharmaceutical USD 59M 4M Jun/2026